An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the safety, efficacy and delineate the
pharmacokinetic properties of nelfinavir in HIV/ Hepatitis C coinfected subjects with Child
Pugh A compensated cirrhosis and or Hepatic fibrosis